| Psoriasis |
1 |
1 |
| Lipids Management |
0 |
0.9 |
| PCSK9 |
0 |
0.99 |
| Cardiovascular Risk Management |
0 |
0.11 |
| Clinical Research |
0 |
0.1 |
| Genetics |
0 |
0.1 |
| Grant |
0 |
0.1 |
| Metabolism |
0 |
0.1 |
| Coronary Artery Disease (CAD) |
0 |
0.07 |
| Genomic Medicine |
0 |
0.07 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Arthritis |
0 |
0.06 |
| Cardiovascular disease |
0 |
0.06 |
| Dyslipidemia |
0 |
0.06 |
| New York |
0 |
0.06 |
| Statins |
0 |
0.06 |
| LDL Cholesterol |
0 |
0.04 |
| Biomarker |
0 |
0.03 |
| Blood |
0 |
0.03 |
| Clinical Guidelines |
0 |
0.03 |
| Hand |
0 |
0.03 |
| Interleukin |
0 |
0.03 |
| Lipoproteins |
0 |
0.03 |
| Preventive Screening |
0 |
0.03 |
| UK Site Content |
0 |
0.03 |
| Biologic Therapy |
0 |
0.02 |